scholarly journals ROLE OF PARTICIPATORY COMMUNICATION IN INFLUENCING MEN’S BEHAVIOUR RESPONSE TO PROSTATE CANCER SCREENING AND TREATMENT IN CENTRAL REGION OF KENYA

2021 ◽  
Vol 06 (01) ◽  
pp. 89-110
Author(s):  
Kahura Ndung’u ◽  
◽  
Juliet Macharia ◽  
Beatrice Ombaka ◽  
◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Behaviour Change ◽  
Central Region ◽  
Health Workers ◽  
Prostate Cancer Screening ◽  
Message Framing ◽  
Communication Strategies ◽  
Early Screening ◽  
Participatory Communication

Prostate cancer (PCa) is one of the leading causes of death among men in the world. Early screening is recommended as one of the prevention measures of the disease. Screening can be encouraged by Behaviour Change Communication (BCC) strategies. These strategies include mass media campaigns, participatory and interpersonal communication, advocacy and message framing. In Kenya, the Central Region is one of the leading regions in PCa prevalence rate. This study therefore examined the participatory communication strategies used in influencing men’s behaviour response towards PCa screening in the region by the Kenyan government. The study was guided by Theory of Reasoned Action. It was anchored on the Pragmatist philosophical paradigm and took a mixed method approach which involved both qualitative and quantitative designs where Key Informant Interviews, Survey and Focus Group Discussions were used to obtain data. A sample of 384 people was picked from an estimated population of 700,010 men aged 40 years and above from the region using simple random sampling. Findings showed that although health workers and communication officials appreciated the role of screening in containing the scourge, the two levels of Kenyan government (County and National) did not put in place sound participatory communication strategies for positive behaviour response to the disease. It is therefore recommended that effective participatory communication strategies for behaviour change be put in place and an annual budget allocated by the governments for this purpose.

scholarly journals CHEK2∗1100delC Mutation and Risk of Prostate Cancer

2014 ◽  
Vol 2014 ◽  
pp. 1-9 ◽  
Author(s):  
Victoria Hale ◽  
Maren Weischer ◽  
Jong Y. Park
Keyword(s):  
Prostate Cancer ◽  
Current Knowledge ◽  
Prostate Cancer Screening ◽  
Critical Role ◽  
Prostate Cancer Risk ◽  
Conclusive Evidence ◽  
Increased Risk ◽  
History Of ◽  
Cancer Studies

Although the causes of prostate cancer are largely unknown, previous studies support the role of genetic factors in the development of prostate cancer.CHEK2plays a critical role in DNA replication by responding to double-stranded breaks. In this review, we provide an overview of the current knowledge of the role of a genetic variant, 1100delC, ofCHEK2on prostate cancer risk and discuss the implication for potential translation of this knowledge into clinical practice. Currently, twelve articles that discussedCHEK2∗1100delC and its association with prostate cancer were identified. Of the twelve prostate cancer studies, five studies had independent data to draw conclusive evidence from. The pooled results of OR and 95% CI were 1.98 (1.23–3.18) for unselected cases and 3.39 (1.78–6.47) for familial cases, indicating thatCHEK2∗1100delC mutation is associated with increased risk of prostate cancer. Screening for CHEK2∗1100delC should be considered in men with a familial history of prostate cancer.

A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population

2016 ◽  
Vol 196 (2) ◽  
pp. 361-366 ◽  
Author(s):  
Robert K. Nam ◽  
Christopher J.D. Wallis ◽  
Jessica Stojcic-Bendavid ◽  
Laurent Milot ◽  
Christopher Sherman ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Prostate Cancer ◽  
Cancer Screening ◽  
Pilot Study ◽  
Magnetic Resonance ◽  
General Population ◽  
Prostate Cancer Screening ◽  
Resonance Imaging

The role of prostate specific antigen measurement in the detection and management of prostate cancer.

2000 ◽  
pp. 37-51 ◽  
Author(s):  
A F Nash ◽  
I Melezinek
Keyword(s):  
Prostate Cancer ◽  
Endocrine Therapy ◽  
Prostate Specific Antigen ◽  
Prostate Cancer Screening ◽  
Specific Antigen ◽  
Marked Change ◽  
Reference Ranges ◽  
Psa Density ◽  
Psa Testing

The introduction of prostate specific antigen (PSA) testing has revolutionised the early detection, management and follow-up of patients with prostate cancer and it is considered to be one of the best biomedical markers currently available in the field of oncology. Its use with annual digital rectal examination in prostate cancer screening programmes has led to a marked change in the distribution of stage at presentation towards earlier disease and led to a significant increase in the detection of potentially curable disease. In order to improve the specificity of PSA testing and thereby reduce the number of unnecessary prostatic biopsies, a number of refinements of PSA evaluation have been proposed. These include free to total PSA ratio, PSA density, PSA density, PSA density of the transition zone, PSA velocity and age-specific PSA reference ranges. The utility of these approaches is considered in this review. The role of PSA monitoring in the detection of recurrence following radical prostatectomy and radiotherapy is discussed, as well as its role in monitoring patients treated with endocrine therapy is discussed, as well as its role in monitoring patients treated with endocrine therapy in terms of correlating PSA response with outcome, in detecting disease progression and in guiding the use of subsequent therapies. Large continuing multicentre screening and outcome studies will provide important information enabling greater refinement of the use of this important diagnostic and monitoring tool in the future detection and management of prostate cancer.

National society-supplied patient materials on prostate cancer screening for the general public: A readability analysis.

2019 ◽  
Vol 37 (15_suppl) ◽  
pp. e23188-e23188
Author(s):  
Michael Kevin Rooney ◽  
Alicia K. Morgans ◽  
Joshua J Meeks ◽  
Shilajit Kundu ◽  
Edward M. Schaeffer ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Screening ◽  
Prostate Cancer Screening ◽  
Professional Society ◽  
National Society ◽  
Reading Levels ◽  
Professional Societies ◽  
Patient Values ◽  
First Time

e23188 Background: Recent data suggest that prostate cancer mortality may be increasing for the first time in 20 years, possibly related to a decrease in PSA screening. Most professional societies recommend men aged 55 to 69 make screening decisions using a shared-decision making (SDM) model. However the quality and time of SDM can vary significantly, often leaving patients uncertain about the implications of pursuing or foregoing screening. In this setting of individualized decisions, patients may seek supplemental information. However, little is known about the accuracy, breadth and readability of available education materials, which if designed optimally could improve SDM. Methods: For 11 predetermined professional societies (ACP, ACPM, ACS, AFP, AMA, ASCO, AUA, CDC, NCI, NIH, USPSTF), patient education materials designed for prostate cancer screening were queried. Materials were analyzed using seven well-validated readability metrics and evaluated for educational content. For content comparison, 10 materials from academic cancer centers and independent organizations were identified using top public search engine results. Results: We identified 12 professional society materials and 20 from popular non-society sources. Mean readability level for society materials ranged from 9.7 to 11.3 grade, well above AMA and NIH recommended 6th and 8th grade reading levels (P < 0.0001). In comparison to general materials, professional society materials more often discussed the role of risk factors in making screening decisions (70% vs 100%, P = 0.03). However, society materials did often omit important guideline-based content, including statements that decisions should involve patient values and preferences (42%) and can vary by patient age (35%). Conclusions: Widely available prostate cancer screening education materials are written at inappropriately high reading levels and often omit important content. Improvement of such materials would encourage SDM for patients considering screening.[Table: see text]

Sign in / Sign up

Export Citation Format

Share Document